All Pharma News
Chemomab to Report Q1 2024 Results, Business Update

Chemomab to Report Q1 2024 Results, Business Update
GLOBENEWSWIRE
24 Apr 2024
Share Share
Chemomab: New Data Links CCL24 To Systemic Sclerosis Severity

Chemomab: New Data Links CCL24 To Systemic Sclerosis Severity
GLOBENEWSWIRE
18 Apr 2024
Share Share
Chemomab Announces Year End and Fourth Quarter 2023 Financial Results

Chemomab Announces Year End and Fourth Quarter 2023 Financial Results
PR NEWSWIRE
07 Mar 2024
Share Share
Chemomab Awarded New Patents for CM-101

Chemomab Awarded New Patents for CM-101
PR NEWSWIRE
20 Feb 2024
Share Share
Chemomab to Report Fourth Quarter and Full Year 2023 Financial Results

Chemomab to Report Fourth Quarter and Full Year 2023 Financial Results
PR NEWSWIRE
14 Feb 2024
Share Share
Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Trial

Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Trial
PR NEWSWIRE
03 Jan 2024
Share Share
Chemomab Presentation at ACR Provides Further Support for Key Role of Its CCL24

Chemomab Presentation at ACR Provides Further Support for Key Role of Its CCL24
PRESS RELEASE
16 Nov 2023
Share Share
Chemomab Therapeutics Receives FDA Fast Track Designation for CM-101

Chemomab Therapeutics Receives FDA Fast Track Designation for CM-101
PRESS RELEASE
15 Nov 2023
Share Share
Chemomab Presents Data for CM-101`s Anti-Fibrotic/Anti-Inflammatory Activity

Chemomab Presents Data for CM-101`s Anti-Fibrotic/Anti-Inflammatory Activity
PRESS RELEASE
13 Nov 2023
Share Share
Chemomab Therapeutics Announces Third Quarter 2023 Financial Results

Chemomab Therapeutics Announces Third Quarter 2023 Financial Results
PR NEWSWIRE
09 Nov 2023
Share Share